Janet L. Espirito, PharmD

home / authors / janet-l-espirito-pharmd

Articles

March 31st 2015

Cost Differential by Site of Service for Cancer Patients Receiving Chemotherapy

Jad Hayes, MS, ASA, MAAA J. Russell Hoverman, MD, PhD Matthew E. Brow, BA Dana C. Dilbeck, BA Diana K. Verrilli, MS Jody Garey, PharmD Janet L. Espirito, PharmD Jorge Cardona, BS Roy Beveridge, MD

The cost of care for patients receiving chemotherapy in community oncology clinics is lower than for comparable patients receiving chemotherapy in the hospital outpatient setting.

May 19th 2011

Pathways, Outcomes, and Costs in Colon Cancer: Retrospective Evaluations in 2 Distinct Databases

J. Russell Hoverman, MD, PhD Thomas H. Cartwright, MD Debra A. Patt, MD, MPH Janet L. Espirito, PharmD Matthew P. Clayton Jody S. Garey, PharmD Terrance J. Kopp Marcus A.

Retrospective evaluations of electronic health records and claims databases to assess clinical outcomes and costs associated with evidence-based pathways in colon cancer.